PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models.
Saved in:
| Title: | PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models. |
|---|---|
| Authors: | Sangotra A; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA., Reddy SL; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA., Kuo CJ; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA., Xiang W; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Merry DE; Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA., Grunseich C; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Wang S; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Lieberman AP; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: liebermn@umich.edu. |
| Source: | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2025 Oct; Vol. 22 (6), pp. e00732. Date of Electronic Publication: 2025 Sep 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1878-7479 |
|---|---|
| DOI: | 10.1016/j.neurot.2025.e00732 |
